One of the key challenges in developing effective, targeted cancer treatments is the heterogeneity of the cancer cells themselves. This variation makes it difficult for the immune system to recognize, respond to and actively ...
Bio & Medicine
Oct 2, 2020
0
646
Scientists in the Department of Biomedical Engineering at Texas A&M University are developing new ways to advance the field of regenerative medicine and cancer treatment. They are developing a 2-D nanosheet that is 1,000 ...
Bio & Medicine
Jun 10, 2020
0
225
A diagnostic tool to assess the risk of a cancer relapse, machines for plastic recycling, an alternative to toxic ship paint— all were among the inventions honoured at the European Inventor Awards on Thursday.
Other
Jun 20, 2019
0
0
University of Montana researchers recently published their new insights into how pathogenic bacteria resist antibiotic treatment in Proceedings of the Natural Academy of Sciences.
Cell & Microbiology
Oct 2, 2018
0
203
Lyme disease is often evident by a rash on the skin, but infections do not always produce similar rashes. This can make it difficult to detect the disease early, when antibiotic treatment is most effective. In the February ...
Biochemistry
Feb 4, 2014
0
0
Biomolecular 'nanocarriers' formed by the careful assembly of protein subunits are common in nature and perform a range of essential roles in biological processes, powered by the biological energy carrier adenosine-5'-triphosphate ...
Biochemistry
Aug 9, 2013
0
84
Researchers report that myxoma – a pox virus that afflicts rabbits but not humans, dogs or any other vertebrates so far studied – infects several different types of canine cancer cells in cell culture while sparing healthy ...
Plants & Animals
Sep 10, 2012
1
0
On the topic of computers, artificial intelligence and robots, Northern Illinois University Professor David Gunkel says science fiction is fast becoming "science fact."
Computer Sciences
Aug 29, 2012
15
0
Many cancer therapies target specific proteins that proliferate on the outside of some cancer cells, but the therapies are imperfect and the cancer does not always respond. Since it is beneficial for doctors to know as soon ...
Optics & Photonics
Dec 20, 2011
0
0
Charles J. Dimitroff, MS, PhD and colleagues in the Dimitroff Lab at Brigham and Women's Hospital, have developed a fluorinated analog of glucosamine, which, in a recent study, has been shown to block the synthesis of key ...
Biochemistry
May 23, 2011
0
0
